Clinical Trial Update: Serp-1 for the Treatment of Acute Coronary Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial of Serp-1 for acute coronary syndrome has been terminated; the study enrolled patients with unstable angina, coronary artery disease, and corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis
• Unstable Angina

Drugs mentioned

• Serp-1

Snippet

Sponsor: Viron Therapeutics Inc | Conditions: Unstable Angina, Coronary Atherosclerosis | Phase 2 | Status: TERMINATED